nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—Rash generalised—Varenicline—nicotine dependence	0.045	0.0519	CcSEcCtD
Temsirolimus—Aphthous stomatitis—Varenicline—nicotine dependence	0.0408	0.047	CcSEcCtD
Temsirolimus—Platelet count decreased—Varenicline—nicotine dependence	0.0321	0.0371	CcSEcCtD
Temsirolimus—Hyperlipidaemia—Varenicline—nicotine dependence	0.0265	0.0306	CcSEcCtD
Temsirolimus—Fungal infection—Varenicline—nicotine dependence	0.0248	0.0286	CcSEcCtD
Temsirolimus—Gingivitis—Varenicline—nicotine dependence	0.0244	0.0281	CcSEcCtD
Temsirolimus—Acne—Varenicline—nicotine dependence	0.0227	0.0262	CcSEcCtD
Temsirolimus—Viral infection—Varenicline—nicotine dependence	0.0212	0.0244	CcSEcCtD
Temsirolimus—Pulmonary embolism—Varenicline—nicotine dependence	0.0191	0.0221	CcSEcCtD
Temsirolimus—Mouth ulceration—Varenicline—nicotine dependence	0.0173	0.0199	CcSEcCtD
Temsirolimus—Diabetes mellitus—Varenicline—nicotine dependence	0.016	0.0184	CcSEcCtD
Temsirolimus—Eczema—Varenicline—nicotine dependence	0.0154	0.0178	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0139	0.016	CcSEcCtD
Temsirolimus—Dry skin—Varenicline—nicotine dependence	0.0127	0.0147	CcSEcCtD
Temsirolimus—Hypokalaemia—Varenicline—nicotine dependence	0.0126	0.0146	CcSEcCtD
Temsirolimus—Gastritis—Varenicline—nicotine dependence	0.0123	0.0142	CcSEcCtD
Temsirolimus—Abdominal distension—Varenicline—nicotine dependence	0.0121	0.0139	CcSEcCtD
Temsirolimus—Dysphagia—Varenicline—nicotine dependence	0.012	0.0138	CcSEcCtD
Temsirolimus—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0119	0.0891	CbGpPWpGaD
Temsirolimus—Bronchitis—Varenicline—nicotine dependence	0.0115	0.0133	CcSEcCtD
Temsirolimus—Pollakiuria—Varenicline—nicotine dependence	0.0111	0.0128	CcSEcCtD
Temsirolimus—Hyperglycaemia—Varenicline—nicotine dependence	0.0108	0.0125	CcSEcCtD
Temsirolimus—Infestation NOS—Varenicline—nicotine dependence	0.0107	0.0123	CcSEcCtD
Temsirolimus—Infestation—Varenicline—nicotine dependence	0.0107	0.0123	CcSEcCtD
Temsirolimus—Depression—Varenicline—nicotine dependence	0.0107	0.0123	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0106	0.0122	CcSEcCtD
Temsirolimus—Stomatitis—Varenicline—nicotine dependence	0.0104	0.012	CcSEcCtD
Temsirolimus—Conjunctivitis—Varenicline—nicotine dependence	0.0104	0.012	CcSEcCtD
Temsirolimus—Epistaxis—Varenicline—nicotine dependence	0.0101	0.0116	CcSEcCtD
Temsirolimus—Sinusitis—Varenicline—nicotine dependence	0.01	0.0116	CcSEcCtD
Temsirolimus—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00986	0.0739	CbGpPWpGaD
Temsirolimus—Urinary tract disorder—Varenicline—nicotine dependence	0.00948	0.0109	CcSEcCtD
Temsirolimus—Oedema peripheral—Varenicline—nicotine dependence	0.00946	0.0109	CcSEcCtD
Temsirolimus—Connective tissue disorder—Varenicline—nicotine dependence	0.00943	0.0109	CcSEcCtD
Temsirolimus—Urethral disorder—Varenicline—nicotine dependence	0.00941	0.0109	CcSEcCtD
Temsirolimus—Erythema multiforme—Varenicline—nicotine dependence	0.00908	0.0105	CcSEcCtD
Temsirolimus—Eye disorder—Varenicline—nicotine dependence	0.00897	0.0104	CcSEcCtD
Temsirolimus—Cardiac disorder—Varenicline—nicotine dependence	0.00891	0.0103	CcSEcCtD
Temsirolimus—Angiopathy—Varenicline—nicotine dependence	0.00871	0.01	CcSEcCtD
Temsirolimus—Immune system disorder—Varenicline—nicotine dependence	0.00867	0.01	CcSEcCtD
Temsirolimus—Mediastinal disorder—Varenicline—nicotine dependence	0.00865	0.00998	CcSEcCtD
Temsirolimus—Chills—Varenicline—nicotine dependence	0.00861	0.00994	CcSEcCtD
Temsirolimus—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00859	0.0644	CbGpPWpGaD
Temsirolimus—Mental disorder—Varenicline—nicotine dependence	0.00841	0.0097	CcSEcCtD
Temsirolimus—Malnutrition—Varenicline—nicotine dependence	0.00836	0.00964	CcSEcCtD
Temsirolimus—Erythema—Varenicline—nicotine dependence	0.00836	0.00964	CcSEcCtD
Temsirolimus—Dysgeusia—Varenicline—nicotine dependence	0.00818	0.00944	CcSEcCtD
Temsirolimus—Back pain—Varenicline—nicotine dependence	0.00808	0.00933	CcSEcCtD
Temsirolimus—Anaemia—Varenicline—nicotine dependence	0.00772	0.00891	CcSEcCtD
Temsirolimus—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00769	0.0577	CbGpPWpGaD
Temsirolimus—Angioedema—Varenicline—nicotine dependence	0.00763	0.00881	CcSEcCtD
Temsirolimus—Cough—Varenicline—nicotine dependence	0.00729	0.00841	CcSEcCtD
Temsirolimus—Convulsion—Varenicline—nicotine dependence	0.00724	0.00835	CcSEcCtD
Temsirolimus—Hypertension—Varenicline—nicotine dependence	0.00721	0.00832	CcSEcCtD
Temsirolimus—Myalgia—Varenicline—nicotine dependence	0.00711	0.00821	CcSEcCtD
Temsirolimus—Chest pain—Varenicline—nicotine dependence	0.00711	0.00821	CcSEcCtD
Temsirolimus—Arthralgia—Varenicline—nicotine dependence	0.00711	0.00821	CcSEcCtD
Temsirolimus—Anxiety—Varenicline—nicotine dependence	0.00709	0.00818	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00706	0.00815	CcSEcCtD
Temsirolimus—Oedema—Varenicline—nicotine dependence	0.00682	0.00787	CcSEcCtD
Temsirolimus—Infection—Varenicline—nicotine dependence	0.00677	0.00782	CcSEcCtD
Temsirolimus—Nervous system disorder—Varenicline—nicotine dependence	0.00669	0.00772	CcSEcCtD
Temsirolimus—Thrombocytopenia—Varenicline—nicotine dependence	0.00668	0.0077	CcSEcCtD
Temsirolimus—Skin disorder—Varenicline—nicotine dependence	0.00662	0.00764	CcSEcCtD
Temsirolimus—Anorexia—Varenicline—nicotine dependence	0.0065	0.0075	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00621	0.00717	CcSEcCtD
Temsirolimus—Insomnia—Varenicline—nicotine dependence	0.00617	0.00712	CcSEcCtD
Temsirolimus—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00611	0.0458	CbGpPWpGaD
Temsirolimus—Dyspnoea—Varenicline—nicotine dependence	0.00608	0.00702	CcSEcCtD
Temsirolimus—Somnolence—Varenicline—nicotine dependence	0.00606	0.007	CcSEcCtD
Temsirolimus—Decreased appetite—Varenicline—nicotine dependence	0.00593	0.00684	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00589	0.00679	CcSEcCtD
Temsirolimus—Fatigue—Varenicline—nicotine dependence	0.00588	0.00678	CcSEcCtD
Temsirolimus—Constipation—Varenicline—nicotine dependence	0.00583	0.00673	CcSEcCtD
Temsirolimus—Pain—Varenicline—nicotine dependence	0.00583	0.00673	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Varenicline—nicotine dependence	0.00558	0.00643	CcSEcCtD
Temsirolimus—Body temperature increased—Varenicline—nicotine dependence	0.00539	0.00622	CcSEcCtD
Temsirolimus—Abdominal pain—Varenicline—nicotine dependence	0.00539	0.00622	CcSEcCtD
Temsirolimus—Hypersensitivity—Varenicline—nicotine dependence	0.00502	0.0058	CcSEcCtD
Temsirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00494	0.037	CbGpPWpGaD
Temsirolimus—Asthenia—Varenicline—nicotine dependence	0.00489	0.00565	CcSEcCtD
Temsirolimus—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00487	0.0365	CbGpPWpGaD
Temsirolimus—Pruritus—Varenicline—nicotine dependence	0.00482	0.00557	CcSEcCtD
Temsirolimus—Diarrhoea—Varenicline—nicotine dependence	0.00467	0.00538	CcSEcCtD
Temsirolimus—Dizziness—Varenicline—nicotine dependence	0.00451	0.0052	CcSEcCtD
Temsirolimus—Vomiting—Varenicline—nicotine dependence	0.00434	0.005	CcSEcCtD
Temsirolimus—Rash—Varenicline—nicotine dependence	0.0043	0.00496	CcSEcCtD
Temsirolimus—Dermatitis—Varenicline—nicotine dependence	0.0043	0.00496	CcSEcCtD
Temsirolimus—Headache—Varenicline—nicotine dependence	0.00427	0.00493	CcSEcCtD
Temsirolimus—Nausea—Varenicline—nicotine dependence	0.00405	0.00467	CcSEcCtD
Temsirolimus—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.004	0.03	CbGpPWpGaD
Temsirolimus—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.004	0.0299	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—OPRM1—nicotine dependence	0.00399	0.0299	CbGpPWpGaD
Temsirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00357	0.0267	CbGpPWpGaD
Temsirolimus—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00352	0.0264	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00303	0.0227	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00298	0.0224	CbGpPWpGaD
Temsirolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00289	0.0217	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00286	0.0214	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—WASF2—nicotine dependence	0.00282	0.0211	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—WASF1—nicotine dependence	0.0027	0.0202	CbGpPWpGaD
Temsirolimus—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00254	0.019	CbGpPWpGaD
Temsirolimus—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0025	0.0188	CbGpPWpGaD
Temsirolimus—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00226	0.0169	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—FGD1—nicotine dependence	0.00218	0.0164	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00213	0.0159	CbGpPWpGaD
Temsirolimus—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0021	0.0157	CbGpPWpGaD
Temsirolimus—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00206	0.0154	CbGpPWpGaD
Temsirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00166	0.0124	CbGpPWpGaD
Temsirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00164	0.0123	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00163	0.0122	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00154	0.0115	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00152	0.0114	CbGpPWpGaD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00135	0.0101	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00116	0.00869	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00109	0.00819	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00108	0.00808	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00106	0.00797	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKR1B10—nicotine dependence	0.00105	0.00788	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGD1—nicotine dependence	0.000834	0.00625	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—WASF2—nicotine dependence	0.000775	0.00581	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000758	0.00568	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—WASF1—nicotine dependence	0.000743	0.00557	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000737	0.00552	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000714	0.00535	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000705	0.00528	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TAS2R16—nicotine dependence	0.000598	0.00448	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKR1B10—nicotine dependence	0.000592	0.00443	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—WASF2—nicotine dependence	0.000519	0.00389	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—WASF1—nicotine dependence	0.000498	0.00373	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGD1—nicotine dependence	0.000469	0.00352	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—WASF2—nicotine dependence	0.000452	0.00338	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—OPRM1—nicotine dependence	0.000448	0.00336	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—WASF1—nicotine dependence	0.000433	0.00324	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000423	0.00317	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKR1B10—nicotine dependence	0.000414	0.00311	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000364	0.00272	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DRD2—nicotine dependence	0.000324	0.00243	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—WASF2—nicotine dependence	0.000292	0.00219	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—WASF1—nicotine dependence	0.00028	0.0021	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000263	0.00197	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—OPRM1—nicotine dependence	0.000252	0.00189	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000198	0.00149	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000187	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DRD2—nicotine dependence	0.000182	0.00137	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000122	0.000916	CbGpPWpGaD
